<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-112787</identifier>
<setSpec>0004-0614</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The role of ischemia in the deterioration of renal function after partial nephrectomy</dc:title>
<dc:description xml:lang="en">OBJECTIVES: Nephron-sparing surgery (NSS) has been considered throughout history for patients with solitary kidney, bilateral renal tumors, impaired renal function, and hereditary renal cancer. However, recently the indications for Partial Nephrectomy (PN) have extended and include patients with a healthy contralateral kidney. NSS has evolved in a great way during the last decade, specifically in terms of oncological indications, and in the renal ischemia time used with the goal to maintain as much renal function as possible. This change is secondary to a better understanding of renal cancer histology, the equivalence in oncological outcomes between radical and PN, and finally the impact of chronic kidney disease (CKD) as a cause of cardiovascular complications and mortality. The main purpose of our study is to review the role of ischemia in NSS. METHODS: A literature review was performed focusing on NSS, risk factors of renal damage, types of ischemia, as well as its effect on renal function, and ischemia time. CONCLUSIONS: Renal ischemia has been considered for a long time as the main factor related with postoperative Renal Function (RF) in patients with NSS. Furthermore it is one of the few modifiable factors that directly depend on the surgeon. The ischemia time limit, both in warm and cold, is not well established and is a controversial issue that is still on debate till now. At this moment, there is evidence that considers the impact of ischemia only in acute or early stages. Also other factors have emerged and seem to have greater effect on RF, mainly in the long-term, leaving ischemia in second place. These factors are the quantity and quality of the remaining renal parenchyma. More studies are needed to support this rising concept and to clarify the real part that ischemia plays (AU)</dc:description>
<dc:creator>Arceo-Olaiz, Ricardo</dc:creator>
<dc:creator>Hernández, Virginia</dc:creator>
<dc:creator>Morena, José Manuel de la</dc:creator>
<dc:creator>Llorente, Carlos</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">OBJETIVO: Históricamente se ha considerado la Cirugía Renal Conservadora (CRC) en pacientes con riñón solitario, tumores bilaterales, alteración en la función renal y cáncer renal hereditario. Sin embargo en la actualidad las indicaciones de nefrectomía parcial se han extendido a pacientes con riñón contralateral sano. La CRC ha evolucionado de manera muy importante en la última década, específicamente en términos de indicaciones oncológicas y en el tiempo de isquemia renal utilizado con el objetivo de mantener la función renal posible. El objetivo principal de este estudio es realizar una revisión del papel que tiene la isquemia en la CRC. MÉTODOS: Se llevó a cabo una revisión de la literatura enfocada en CRC, factores de riesgo de daño renal, tipos de isquemia así como su duración y efecto sobre la Función Renal (FR). CONCLUSIONES: La isquemia renal ha sido considerada durante muchos años como el principal factor asociado con la FR postoperatoria en pacientes intervenidos de CRC. A su vez, es uno de los pocos factores modificables que dependen directamente del cirujano. El tiempo límite de isquemia, tanto caliente como fría, no está bien establecido. En la actualidad existe evidencia que considera el impacto de la isquemia limitado solamente a etapas tempranas o agudas. Asimismo han surgido otros factores que parecen tener mayor efecto sobre la FR, principalmente a largo plazo, dejando a la isquemia en un segundo plano. Dichos factores son la cantidad y calidad del parénquima renal residual. Se requieren más estudios que refuercen este concepto emergente y que nos aclaren el papel real de la isquemia (AU)</dc:description>
<dc:source>Arch Esp Urol;66(4): 350-358, mayo 2013. tab</dc:source>
<dc:identifier>ibc-112787</dc:identifier>
<dc:title xml:lang="es">Papel de la isquemia en el deterioro de la función renal tras nefrectomía parcial</dc:title>
<dc:subject>^d7678^s22032</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d11622</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d50495^s22027</dc:subject>
<dc:subject>^d9585^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201305</dc:date>
</metadata>
</record>
</ibecs-document>
